JAMA Oncology,
Neo-Bioscore from ERBB2/HER2
Neo-Bioscore from ERBB2/HER2
This study evaluates an update to a previously validated breast cancer staging system by incorporating the latest definition of…
This study evaluates an update to a previously validated breast cancer staging system by incorporating the latest definition of…
This study defines a new prognostic system called "Neo-Bioscore" that incorporates ERBB2 (formerly HER2/neu or HER2) status…